Total Payments
$717.60
2024 Payments
$169.98
Companies
12
Transactions
31
Medicare Patients
2,435
Medicare Billing
$488,664
Payment Breakdown by Category
Food & Beverage$632.61 (88.2%)
Education$84.99 (11.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $632.61 | 30 | 88.2% |
| Education | $84.99 | 1 | 11.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IBSA Pharma Inc. | $204.60 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $131.22 | 3 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $89.07 | 4 | $0 (2019) |
| Evofem Biosciences, Inc. | $64.53 | 3 | $0 (2021) |
| PFIZER INC. | $59.69 | 3 | $0 (2024) |
| Romark Laboratories, LC | $46.72 | 2 | $0 (2020) |
| Corcept Therapeutics | $40.45 | 2 | $0 (2024) |
| Azurity Pharmaceuticals, Inc. | $23.35 | 1 | $0 (2023) |
| Phadia US Inc. | $17.12 | 1 | $0 (2017) |
| Purdue Pharma L.P. | $16.58 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $169.98 | 8 | IBSA Pharma Inc. ($69.84) |
| 2023 | $201.54 | 6 | Astellas Pharma US Inc ($131.22) |
| 2022 | $45.42 | 2 | IBSA Pharma Inc. ($45.42) |
| 2021 | $86.86 | 4 | Evofem Biosciences, Inc. ($64.53) |
| 2020 | $56.45 | 2 | Romark Laboratories, LC ($36.41) |
| 2019 | $51.20 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($51.20) |
| 2018 | $48.18 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($37.87) |
| 2017 | $57.97 | 4 | Phadia US Inc. ($17.12) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Endocrinology | ||||||
| 05/24/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $23.19 | General |
| Category: Endocrinology | ||||||
| 04/30/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Endocrinology | ||||||
| 03/06/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $23.19 | General |
| Category: Endocrinology | ||||||
| 11/15/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Biological | ||||||
| 11/05/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $23.19 | General |
| Category: non-opioid analgesic | ||||||
| 10/31/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $84.99 | General |
| 10/02/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Biological | ||||||
| 05/16/2023 | Azurity Pharmaceuticals, Inc. | Adthyza (Drug) | Food and Beverage | Cash or cash equivalent | $23.35 | General |
| Category: Endocrinology | ||||||
| 02/12/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $23.78 | General |
| Category: non-opioid analgesic | ||||||
| 08/09/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $23.78 | General |
| Category: Endocrinology | ||||||
| 02/04/2022 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $21.64 | General |
| Category: Endocrinology | ||||||
| 10/25/2021 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 10/01/2021 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $22.33 | General |
| Category: Endocrinology | ||||||
| 03/09/2021 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 01/06/2021 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 09/21/2020 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $20.04 | General |
| Category: Endocrinology | ||||||
| 07/22/2020 | Romark Laboratories, LC | ALINIA (Drug), ALINIA, ALINIA | Food and Beverage | In-kind items and services | $36.41 | General |
| Category: Gastroenterology | ||||||
| 04/20/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/20/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,083 | 2,375 | $456,502 | $171,351 |
| 2022 | 6 | 339 | 985 | $230,870 | $82,600 |
| 2021 | 6 | 465 | 1,255 | $303,600 | $120,260 |
| 2020 | 7 | 548 | 1,571 | $377,125 | $114,454 |
Total Patients
2,435
Total Services
6,186
Medicare Billing
$488,664
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 918 | $239,340 | $87,889 | 36.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 110 | 234 | $39,780 | $15,534 | 39.0% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Office | 2023 | 154 | 382 | $36,345 | $14,379 | 39.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 39 | 43 | $33,330 | $12,760 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 134 | $24,985 | $9,680 | 38.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 52 | $15,531 | $6,962 | 44.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $7,000 | $4,575 | 65.4% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 29 | 31 | $9,540 | $3,809 | 39.9% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 32 | 37 | $9,320 | $3,654 | 39.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 26 | 72 | $9,510 | $3,485 | 36.6% |
| 0358T | Whole body composition tissue and fluid measurements with interpretation and report | Office | 2023 | 72 | 93 | $6,350 | $1,876 | 29.5% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 13 | 17 | $3,060 | $1,196 | 39.1% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 36 | 39 | $2,890 | $1,085 | 37.5% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 34 | 37 | $2,730 | $1,000 | 36.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 38 | 47 | $2,350 | $833.85 | 35.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 18 | $2,160 | $826.38 | 38.3% |
| 99423 | Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | Office | 2023 | 15 | 18 | $1,710 | $682.48 | 39.9% |
| 94680 | Test to measure exhaled air for evaluation of lung function during rest and exercise | Office | 2023 | 19 | 19 | $3,800 | $467.94 | 12.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 35 | $1,210 | $388.70 | 32.1% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 13 | 13 | $536.00 | $136.89 | 25.5% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 22 | 51 | $2,525 | $100.96 | 4.0% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2023 | 21 | 50 | $2,500 | $31.31 | 1.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 193 | 800 | $200,000 | $71,334 | 35.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 44 | 53 | $7,600 | $4,164 | 54.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $5,600 | $2,156 | 38.5% |
About Dr. Herbert Slavin, MD
Dr. Herbert Slavin, MD is a Internal Medicine healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528018512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Herbert Slavin, MD has received a total of $717.60 in payments from pharmaceutical and medical device companies, with $169.98 received in 2024. These payments were reported across 31 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($632.61).
As a Medicare-enrolled provider, Slavin has provided services to 2,435 Medicare beneficiaries, totaling 6,186 services with total Medicare billing of $488,664. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lauderhill, FL
- Active Since 05/11/2006
- Last Updated 01/27/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528018512
Products in Payments
- Tirosint (Drug) $157.63
- XIFAXAN (Drug) $89.07
- Phexxi (Drug) $64.53
- ELIQUIS (Drug) $59.69
- LICART (Drug) $46.97
- Veozah (Drug) $46.23
- Korlym (Drug) $40.45
- ALINIA (Drug) $36.41
- Adthyza (Drug) $23.35
- ImmunoCAP (Device) $17.12
- OXYCONTIN (Drug) $16.58
- XTAMPZA ER (Drug) $12.62
- NP Thyroid (Drug) $11.65
- Alinia Tablets 500mg 30 count bottle (Drug) $10.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lauderhill
Dr. Ross Nochimson, M.d, M.D
Internal Medicine — Payments: $10,283
Internal Medicine $10,283
Dr. Sean Nochimson, D.o, D.O
Internal Medicine — Payments: $3,872
Internal Medicine $3,872
Dr. Jessica Geller, M.d, M.D
Internal Medicine — Payments: $990.36
Internal Medicine $990.36
Dr. Daniel Leon Roumain, M.d, M.D
Internal Medicine — Payments: $610.80
Internal Medicine $610.80
Dr. John Wolf, M.d, M.D
Internal Medicine — Payments: $189.45
Internal Medicine $189.45
Natasha Cedeno, M.d, M.D
Internal Medicine — Payments: $47.29
Internal Medicine $47.29